甲基丙二酸血症肾脏管理临床实践推荐:ERKNet与MetabERN专家共识
该共识由欧洲罕见肾病参考网络与欧洲遗传代谢病参考网络联合制定,聚焦甲基丙二酸血症(MMA)患者的慢性肾脏病(CKD)、透析与肾移植管理。共识指出基于肌酐的公式会显著高估肾功能,建议用胱抑素C估算eGFR;急性透析可用于急性代谢失代偿清除毒素,长期透析需长时或每日血液透析;CKD患者应优先考虑肝肾联合移植。共形成13条推荐意见。
要点
- 基于肌酐的公式显著高估MMA患者肾功能,应使用胱抑素C估算eGFR。
- 急性代谢失代偿时可急诊透析清除代谢毒素,长期透析需长时或每日HD。
- MMA合并CKD患者移植应优先选择肝肾联合移植(LKT)。
核心结论
- CKD是MMA常见并发症,需在儿科和成人科室进行特定随访。
- 基于肌酐的公式显著高估肾功能,胱抑素C估算eGFR更准确。
- MMA合并CKD患者应优先选择肝肾联合移植。
研究设计与样本
- 由欧洲罕见肾病参考网络与欧洲遗传代谢病参考网络联合制定的临床实践推荐。
- 制定组包括儿科和成人肾内科医生、代谢病专家及肝移植和肾移植专家。
主要发现
- CKD已成为MMA重要临床问题,需儿科和成人科室特定随访。
- 急性代谢失代偿时可能需急诊透析清除代谢毒素。
- 长期透析可用于清除毒性代谢物,需长时血液透析和/或每日透析。
- 使用钙调神经磷酸酶抑制剂(CNIs)可能引起神经毒性,需监测和调整免疫抑制治疗。
关键数值与推荐
- 移植指征包括高频率代谢失代偿、高疾病负担和代谢控制困难。
- 出现长期并发症时也指示移植。
- 共形成13条推荐意见,涵盖CKD、透析和移植管理。
临床怎么用
- MMA患者应使用胱抑素C而非肌酐公式评估eGFR。
- 急性代谢失代偿时可考虑急诊透析清除代谢毒素。
- 长期透析需采用长时血液透析和/或每日透析。
- MMA合并CKD患者移植应优先选择肝肾联合移植。
- 使用CNIs时需监测神经毒性并调整免疫抑制方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Methylmalonic acidemias (MMAs) are rare inherited metabolic diseases with multiorgan involvement. Chronic kidney disease (CKD) is a common complication, leading to kidney failure, dialysis, and kidney transplantation (KT). The objective of these guidelines was to develop clinical practice recommendations focusing on specific aspects of the kidney management of this disease. Development of these clinical practice recommendations is an initiative of the European Reference Network for Rare Kidney Diseases in collaboration with the European Reference Network for Hereditary Metabolic Disorders and included pediatric and adult nephrologists, metabolic specialists, as well as liver and kidney transplant specialists. CKD has become a significant clinical issue that requires specific follow-up in both pediatric and adult departments. Creatinine-based formulae significantly overestimate kidney function and the estimation of estimated glomerular filtration rate (eGFR) is more accurate using cystatin C. Besides usual kidney indications, acute dialysis may be required in emergency in case of acute metabolic decompensation to clear metabolic toxins. Long-term dialysis may be initiated for clearance of toxic metabolites. Long hours on hemodialysis (HD) and/or daily dialysis are required. The indications for transplantation in MMA are a high rate of metabolic decompensations, a high burden of disease and difficult metabolic control. Transplantation is also indicated in case of long-term complications. Combined liver-kidney transplantation (LKT) should be preferred in patients with MMA with CKD. Possible calcineurin inhibitors (CNIs) induced neurotoxicity was described in patients with MMA requiring immunosuppressive treatment monitoring and adaptation. Overall, 13 statements were produced to provide guidance on the management of CKD, dialysis, and transplantation in pediatric and adult patients with MMA.
引用
- Servais A, Zacchia M, Dehoux L, et al. Clinical Practice Recommendations on Kidney Management in Methylmalonic Acidemia: an Expert Consensus Statement From ERKNet and MetabERN. Kidney Int Rep. 2024. PMID: 39698355. doi:10.1016/j.ekir.2024.09.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。